1.
Rev. esp. enferm. dig
; 114(2): 127-128, febrero 2022. ilus
Article
in Spanish
| IBECS
| ID: ibc-205569
2.
Rev Esp Enferm Dig
; 114(2): 127-128, 2022 Feb.
Article
in English
| MEDLINE
| ID: mdl-34743523
ABSTRACT
Cancer immunotherapy is an increasingly common treatment option based on anti-tumor immune response. However, a challenge is arising regarding its potential, which is the poorly understood recognized immune-mediated adverse effects.